Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01636076 · COMPLETED
Trial details
- NCT number
- NCT01636076
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-09-01
- Enrollment
- 629
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.